Scaling medication
access with clinical AI

At Ochsner Health, we choose like-minded partners to help us deliver exceptional care and drive innovation. Together, we are shaping a future of enhanced patient outcomes and streamlined workflows for our providers. From day one, Latent has exemplified what it means to be a trusted partner, aligning with our long-term vision for success. It is a privilege to work with Latent, and we are excited to further strengthen this collaboration, building new efficiencies and setting new standards of excellence across our system.”

Our specialty pharmacy was spending too much time doing administrative tasks, and morale started slipping. Once Latent took that body of work off their plates, our team’s energy skyrocketed. That enthusiasm—‘the Big Mo’—is invaluable. With a reinvigorated team, we’ve been able to focus on what matters most: delivering exceptional care to more patients in need.”

From day one, Latent has exemplified what it means to be a trusted partner, aligning with our long-term vision for success. It is a privilege to work with Latent, and we are excited to further strengthen this collaboration, building new efficiencies and setting new standards of excellence across our system."

Before Latent, the manual PA process could significantly delay therapy initiation. Now, we’re accelerating time-to-therapy and ensuring patients can start their medications as soon as possible.”

When you talk to our primary care providers, they will tell you it takes a skilled professional to dig through charts to complete a prior authorization. Latent’s real superpower is taking on that heavy lifting behind the scenes, so our top clinical talent can stay focused on what truly matters: caring for patients.”

Latent has transformed our collaboration into a true partnership, revolutionizing our prior authorization process and enabling us to expand into a comprehensive medication access and affordability team here at MetroHealth. Thanks to their innovation, we ensure that patients—regardless of socioeconomic status—receive the essential therapies they need."

Every January, we had to reauthorize thousands of patients—a process that used to stretch until mid-March. With Latent, we’ve cut that time by 50% and now finish within the same month."